stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Mink Therapeutics IncINKT
$9.501.71%0.16

Mink Therapeutics Inc (INKT)

Mink Therapeutics Inc Stock (INKT) Forecast

The Mink Therapeutics Inc (INKT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $9.33, representing a -1.84% decrease from the current price of $9.50. The highest analyst price target is $16.31, and the lowest is $2.34.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month INKT Price Target
Average 9.13 (-3.93% Downside)

Is Mink Therapeutics Inc (INKT) A Buy Now?

Oscillators
NameValueAction
RSI(14)38.67Neutral
STOCH(9,6)21.77Neutral
STOCHRSI(14)15.02Buy
MACD(12,26)-0.36Sell
ADX(14)17.94Neutral
William %R-79.84Neutral
CCI(14)-124.15Sell
Buy: 1 · Sell: 2 · Neutral: 4Summary: Neutral
Moving Averages
PeriodSimpleExponential
MA10
10.07
Sell
9.95
Sell
MA20
10.31
Sell
10.24
Sell
MA50
11.06
Sell
10.73
Sell
MA100
11.11
Sell
11.04
Sell
MA200
11.18
Sell
11.66
Sell
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, INKT could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on INKT, as trading bearish markets can be challenging and may result in losses.

  1. RSI (Relative Strength Index): The RSI(14) value of 38.67 indicates that INKT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 21.77 indicates that INKT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 15.02 indicates that INKT is oversold. This suggests that INKT price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of 17.94 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of -124.15 indicates that INKT is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term INKT price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Mink Therapeutics Inc financial reports and earnings history, Mink Therapeutics Inc (INKT) stock could reach $61.60 by 2030, $59.92 by 2040 and $123.24 by 2050. See the projected annual prices until 2050 of the Mink Therapeutics Inc stock below:

  • Mink Therapeutics Inc (INKT) is expected to reach an average price of $22.10 in 2035, with a high prediction of $33.35 and a low estimate of $25.05. This indicates an +132.61% change from the last recorded price of $9.50.
  • Mink Therapeutics Inc (INKT) stock is projected to chart a bullish course in 2040, with an average price target of $49.85, representing an +424.74% change from its current level. The forecast ranges from a conservative $49.52 to a sky-high $59.92.
  • Our analysts predict Mink Therapeutics Inc (INKT) to change +729.42% by 2045, soaring from $76.79 to an average price of $78.79, potentially reaching $85.40. While $76.79 is the low estimate, the potential upside is significant.
  • Mink Therapeutics Inc (INKT) stock is expected to climb by 2050, reaching an average of $104.46, a +999.61% change from its current level. However, a wide range of estimates exists, with high and low targets of $123.24 and $102.06, respectively, highlighting the market's uncertainty.

Mink Therapeutics Inc Stock (INKT) Year by Year Forecast

Mink Therapeutics Inc Stock (INKT) Price Forecast for 2026

The predicted value for Mink Therapeutics Inc (INKT) in 2026 is set at an average of $10.78. Estimates vary from a peak of $28.34 to a trough of $2.34, indicating an +13.47% surge from the present price of $9.50.

MonthAverageLowHighChange from today's price
December, 2026$3.92$2.34$16.31-58.73%

Mink Therapeutics Inc Stock (INKT) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Mink Therapeutics Inc (INKT) is $8.81, with a high forecast of $16.61 and a low forecast of $1.64. This indicates an -7.24% decrease from the last price of $9.50.

MonthAverageLowHighChange from today's price
January, 2027$7.56$1.64$5.96-20.41%
February, 2027$9.20$5.19$2.97-3.14%
March, 2027$4.15$8.92$7.84-56.29%
April, 2027$11.79$7.26$6.79+24.14%
May, 2027$14.34$15.83$16.61+50.98%
June, 2027$16.38$16.26$14.48+72.46%
July, 2027$16.32$16.73$16.15+71.84%
August, 2027$6.18$7.18$15.43-35.00%
September, 2027$5.32$5.32$2.59-44.04%
October, 2027$10.06$8.95$6.76+5.86%
November, 2027$1.49$7.01$7.78-84.28%
December, 2027$2.95$2.22$5.78-68.97%

Mink Therapeutics Inc Stock (INKT) Price Forecast for 2028

In 2028, Mink Therapeutics Inc (INKT) is projected to reach an average price of $7.00, with a high projection of $12.97 and a low estimate of $0.9715. This indicates an -26.37% fall from the last price of $9.50.

MonthAverageLowHighChange from today's price
January, 2028$4.01$3.06$2.98-57.77%
February, 2028$4.47$5.24$4.44-52.91%
March, 2028$5.88$6.46$5.84-38.12%
April, 2028$4.42$6.60$5.35-53.48%
May, 2028$5.17$6.47$6.35-45.58%
June, 2028$8.01$9.48$7.01-15.68%
July, 2028$1.94$4.36$6.68-79.59%
August, 2028$6.70$0.9715$8.13-29.45%
September, 2028$6.54$6.91$6.32-31.13%
October, 2028$9.59$7.25$8.79+0.98%
November, 2028$12.83$10.95$10.47+35.09%
December, 2028$14.37$12.70$12.97+51.25%

Mink Therapeutics Inc Stock (INKT) Price Forecast for 2029

The 2029 price forecast for Mink Therapeutics Inc Stock (INKT) is $11.63 on average, with a high prediction of $13.14 and a low estimate of $10.74. This represents an +22.47% increase from the previous price of $9.50.

MonthAverageLowHighChange from today's price
January, 2029$12.82$12.84$12.89+35.00%
February, 2029$12.47$12.64$12.16+31.21%
March, 2029$12.42$12.00$11.78+30.69%
April, 2029$12.76$13.35$13.14+34.28%
May, 2029$12.00$12.29$12.16+26.28%
June, 2029$12.05$12.20$12.12+26.89%
July, 2029$10.79$11.26$11.48+13.56%
August, 2029$10.73$10.92$10.70+12.93%
September, 2029$10.82$10.94$10.49+13.91%
October, 2029$10.54$10.82$10.38+10.90%
November, 2029$11.06$10.74$10.55+16.43%
December, 2029$11.17$11.08$10.82+17.61%

Mink Therapeutics Inc Stock (INKT) Price Forecast for 2030

Mink Therapeutics Inc Stock (INKT) is expected to reach an average price of $7.96 in 2030, with a high forecast of $61.60 and a low forecast of $0.3232. This signifies an -16.23% decrease from the last price of $9.50.

MonthAverageLowHighChange from today's price
January, 2030$11.64$11.18$11.01+22.54%
February, 2030$10.90$11.22$11.10+14.76%
March, 2030$10.31$10.83$10.23+8.49%
April, 2030$10.21$11.14$11.52+7.52%
May, 2030$7.48$8.22$7.86-21.29%
June, 2030$6.36$7.49$6.95-33.01%
July, 2030$6.98$8.20$7.69-26.48%
August, 2030$8.41$7.32$7.16-11.52%
September, 2030$7.67$8.19$7.87-19.31%
October, 2030$7.60$7.69$7.63-20.04%
November, 2030$7.26$7.65$7.19-23.63%
December, 2030$0.6826$0.3232$61.60-92.82%

Similar to INKT